These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29122442)

  • 1. Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease.
    Pampanini V; Inzaghi E; Germani D; Alterio A; Puglianiello A; Alisi A; Nobili V; Cianfarani S
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):71-76. PubMed ID: 29122442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum complement factor 5a levels are associated with nonalcoholic fatty liver disease in obese children.
    Hu W; Wang M; Yin C; Li S; Liu Y; Xiao Y
    Acta Paediatr; 2018 Feb; 107(2):322-327. PubMed ID: 28981167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease.
    Amin S; El Amrousy D; Elrifaey S; Gamal R; Hodeib H
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):117-121. PubMed ID: 28991837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M
    Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.
    Reinehr T; Roth CL
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4479-85. PubMed ID: 18728159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children.
    Flisiak-Jackiewicz M; Bobrus-Chociej A; Tarasów E; Wojtkowska M; Białokoz-Kalinowska I; Lebensztejn DM
    Can J Gastroenterol Hepatol; 2018; 2018():3870454. PubMed ID: 29854715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
    Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
    Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
    Sayın O; Tokgöz Y; Arslan N
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of fetuin-A are associated with moderate-severe hepatic steatosis in young adults.
    Filardi T; Panimolle F; Tiberti C; Crescioli C; Lenzi A; Pallotta N; Morano S
    J Endocrinol Invest; 2021 Jan; 44(1):105-110. PubMed ID: 32350824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects.
    Sato M; Kamada Y; Takeda Y; Kida S; Ohara Y; Fujii H; Akita M; Mizutani K; Yoshida Y; Yamada M; Hougaku H; Takehara T; Miyoshi E
    Liver Int; 2015 Mar; 35(3):925-35. PubMed ID: 25627311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
    Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
    World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
    Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
    Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.